Essais liés2clinical trials
VilleStrasbourglocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07011745

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Xanomeline/Trospium Chloride Capsule Alzheimer Phase 3 NCT07011745 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease RECRUITING
KarXT Alzheimer Phase 3 NCT06976203 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2) RECRUITING